We’re closing up shop early today for Veteran’s Day, and in the spirit of the holiday we’re running a membership special today. Stock Gumshoe will donate 50% of all membership revenue today and tomorrow to Homes for our Troops, an excellent charitable organization that builds specially adapted homes for severely disabled veterans — so for […]
Articles
- Most Relevant
- Most Recent
What to do when the market is looking ugly, and pessimism is trying to sneak in through the back door of our long-running bull market? Look for a purveyor of optimism and see what he says. So that’s the mission today — as interest rate worries (and perhaps fears of political risk) catch enough attention […]
I’ve had a couple readers ask about this one, and it seems fairly interesting, so I thought I’d look into it even though it doesn’t seem to have been particularly actively promoted. The “tease” came in Steve Sjuggerud’s free Daily Wealth newsletter over the weekend, as bait to tempt subscribers into his True Wealth newsletter […]
I always get a lot of food for thought when I go to the Value Investing Congress, so I’ve got a teaser solution and some updates for your Friday File enjoyment but I thought I’d start with some musing about the Congress ideas that percolated to the top for me on the train ride home… […]
This month the temptation to buy, buy, buy is everywhere — at least, it is for an optimist, like me, who does not think we’re quite on the verge of another Great Depression.Ā Stocks across almost every sector are historically cheap — that doesn’t mean they won’t get cheaper, but it may provide some comfort […]
Last week I started taking a look at a Nancy Zambell teaser for her Buried Treasure Under $10 newsletter, and I’ve had quite a few folks chime in that they’d like to hear about her second stock as well … so here goes: Zambell’s pitch is that she finds unknown, undervalued stocks at low prices […]
This month the temptation to buy, buy, buy is everywhere — at least, it is for an optimist, like me, who does not think we’re quite on the verge of another Great Depression.Ā Stocks across almost every sector are historically cheap — that doesn’t mean they won’t get cheaper, but it may provide some comfort […]
This ad touches a lot of bases… something that a newsletter claims has made people wealthy, is somewhat mysterious and secret, and is based on a legal catalyst that’s going to hit in just a few weeks, on March 16… … plus, it gives a newsletter pitchman the opportunity to call our politicians “those clowns […]
Here’s the top of the tease that I just got in my email from Nicholas Vardy, trying to get me to subscribe to his Global Bull Market Alert ($995/year, in case you’re wondering): “On November 15th, a Top Chinese Internet Company’s Announcement Could Send Its Stock Soaring “While China’s economy levels off, its Internet sector […]
The folks at the Motley Fool like to make a lot of the success of their “double down” or “double play” or “triple play” stocks, which generally is a reference to stocks that are either picked by both of the founding Fool brothers (David and Tom Gardner, who together choose the stocks for their flagship […]
The latest ads from Cabot’s Global Stocks Explorer caught my eye with a “bypass the coronavirus” pitch. Here’s how the ad starts: “Bypass the Coronavirusā¦with this hidden gem at the heart of ‘the biggest investment boom in history’ “Operating revenue increased over 70%. “Gross profit surged 122%. “Net income was up over 60%. “Total bookings […]
This pitch sounds quite familiar, and there’s a good reason for that — Ian Wyatt last year pushed quite hard on a favorite special dividend play… and this initially looked like a repeat of that, because the company that paid a huge special dividend around Thanksgiving last year is again paying one right now. How’s […]
When I last wrote, it was to share with you some stocks that the folks at Zacks think will be the winners under President Obama’s White House leadership … but I didn’t finish the job. I gave you two stocks that they appear be touting as beneficiaries of our next president’s policies, but there were […]
The “stock of the month” email teasers from Cabot follow a bit of a formula, but they also sometimes point us to interesting stocks… so we’re going to take a quick look at this latest ad, which I started seeing about a week ago, and see what Timothy Lutts and the Cabot folks are pitching […]
The latest teaser ad for The Crow’s Nest ($99) is focused on an area that I find fascinating, so I thought we’d dig into that one for you — Jimmy Mengel is pitching eSports as the next huge opportunity for investors, akin to getting in early as a team owner or investor in the NFL […]
Fridays are the day I write for you, my dear Irregular friend, so this time you’re getting a teaser solution that I’ve been inspired to write about today, plus a few updates on my Real Money Portfolio stocks. First, those (pretty minor) updates… One of the worst-performing stocks I own over the past year or […]
Robert Hsu has been running this teaser ad for his Asia Edge newsletter for a week or two now, and I’ve gotten enough questions that it seems there’s some demand for the Gumshoe version (ie, the free version) of the answer. It seems unlikely, by the way, that this tease about the “Facebook of China” […]
This ad from the Motley Fool has been around for a while, and they’re now giving away some of the teaser stock names for free — but they’re still keeping one “secret,” so I thought I’d revisit that part of the pitch and let you know who it is. For those who don’t know what […]
This one came in a day or two ago from Louis Navellier, for his Emerging Growth newsletter service. One of my readers suggested a solution, and his solution seems to be a decent guess … but let me get to the details. Navellier thankfully spares us the story of Chinese overall growth — we do […]
The next wireless standard to be adopted by telecom service providers might be the biggest one since 3G enabled the first real “high speed” data and reasonably useful internet access by smart phones. And new wireless standards are always of interest to investors, not least because the growth of smartphones has tracked the improving networks […]
No, Balthasar is not a biotech company. Think fast! Aragorn, Legolas and Gimli. Athos, Porthos and Aramis. Jaclyn, Farrah and Kate. Kirk, Spock and Bones. Barry, Robin and Maurice. Shadrach, Meshach and Abednego. History and culture bestow trios upon us because threesomes keep us rapt. The Three Magi, liking the Gummune as they do, have […]
Dr. KSS will be reporting from the Biotech Showcase in San Francisco in the comments below. Enjoy!
So… what’s going in in the Real Money Portfolio this week, as we close up shop and get ready for a bit of time with family and friends? Ā I do have one buy to share with you today, I decided to pick up some shares of the stock that I wrote to you about a […]
Lots to talk about today… we’ll start with a quick teaser solution, then move on to some big picture thoughts, updates on the changes in my portfolio (a couple small buys), and some other little updates and cogitations. The teaser comes from Mike Cintolo’s Cabot Growth Investor, which is just what it sounds like: a […]
[Ed. Note: Dr. KSS writes about biotech and medicine for the Irregulars. He adheres to our trading restrictions, choses his own topics, and his words and opinions are his own. His past articles and most recent comments can be found at his Stock Gumshoe page.] Dr. Norchi called me at home this morning to provide […]
We don’t have one big story that’s catching my eye today, so I’ll do some catching up and musing for you. We’re heading into a slow week, so it’s likely there won’t be many new articles during Thanksgiving week — other than our annual “Turkey of the Year” reveal, of course. I often get asked […]
All things Uranium: Company research and thesis refinementWho is this for: Investors looking to make explosive profits with time horizons of multiple years What is this for: Exchange of ideas for how to position a portfolio for the next bullish cycle in uranium Why? After 30 hours of preliminary research, I have a strong feeling that we are on the cusp of […]
[ed. note: Michael Jorrin, who I dubbed āDoc Gumshoeā years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends. He does not typically focus onĀ specific investment opportunities, but has agreed to our trading restrictionsā¦ as with all of our authors, he […]
The conference is exclusively one on one meetings that each attendee has with each presenting company, so lots of face time and note taking. I will disperse my notes from this conference in the comment thread below.
So what’s going on in the world this week? Uranium caught my eye… dominant uranium miner Cameco (CCJ) is suspending production at some of their Saskatchewan operations, so the other uranium names took that as a good sign, with the juniors in the space seeing their stock prices pop (the whole sector, as represented by […]
Well, we finish out the week with yet another dramatic performance from the market-dominating tech stocks. Alphabet (GOOG) did better than expected and popped a bit, climbing further through the day, almost as much as the gains Microsoft (MSFT) made on a more dramatic ‘beat’ of expectations (though analysts have always been better at estimating […]
What to do when the market is looking ugly, and pessimism is trying to sneak in through the back door of our long-running bull market? Look for a purveyor of optimism and see what he says. So that’s the mission today — as interest rate worries (and perhaps fears of political risk) catch enough attention […]
Got some spam about these advertising a newsletter called ’The Near Future Report.’ A few details are revealed; you can find the pitch here: https://pros.bonnerandpartners.com/p/1706BNFLAUNCH/PBNFT702/Full For the first one, one of the mentions ’Project Titan.’ But that is an Apple initiative so I doubt that is the key clue. I also think we can rule […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for ourĀ Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
The latest ad for The Casey Report caught my eye this week, partly because I thought they might be following in teasing eCobalt (ECSI)… but it turns out that’s not the case, this pitch from E.B. Tucker about the next cobalt bull market being driven by lithium-ion battery demand is all about two other cobalt […]
How do we get there? >>>—Water, Air, Earth, Fire——-> #Inspired by Dad, Arch1, Griffin, HendrixNuzzles, #ZKSS, Robert Friedland, Matt Bohlsen o ”LOVE is all that matters. Love IS all there is…” ~ Dad, Hours after flight! 😉 o ”Sums it up. just like a coffee maker. Clean out used grounds and repeat as needed. Espresso […]
Today I’ll try to keep my blather a little more limited than usual… I have one update on a stock that I bought recently, and a couple updates on our watchlist this week (that list always lingers down there at the bottom of the Real Money Portfolio, in case you’ve missed it). The update is […]
I’ve written a couple times about Kim Iskyan’s teaser ads over the past year, but this is the first time I’ve seen ads for his higher-end International Capitalist (the last offer was a $3,000 “lifetime” subscription). Iskyan has sold a few investment newsletters over the past decade, first with Stansberry, then later on his own […]
Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
I spent the day on Tuesday at the Delivering Alpha conference, which is hosted by CNBC and Institutional Investor — it’s not the kind of confab that includes “secret” or special ideas that you can’t hear about elsewhere (it’s hosted by CNBC, after all, and they broadcast from the conference all day), but it’s an […]